Dr. Jill O’Donnell-Tormey Discusses the Latest Developments in Immunological Technologies August 16, 2023August 16, 2023 CRI Staff
Two Immunotherapies Clear Important Regulatory Hurdles July 8, 2014December 14, 2022 Matthew Tontonoz
ASH14 Preview: Blood Cancer Developments December 1, 2014December 14, 2022 Jill O'Donnell-Tormey, PhD
New Cancer Immunotherapy Opdivo Approved by FDA December 22, 2014December 14, 2022 Jill O'Donnell-Tormey, PhD